Related Experiment Video
Updated: Jun 1, 2026
06:26
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Polymer therapeutics as nanomedicines: new perspectives
1Polymer Therapeutics Lab., Centro de Investigación Príncipe Felipe, Av. Autopista del Saler 16 E-46012, Valencia, Spain.
Current Opinion in Biotechnology
|June 17, 2011
Summary
Polymer therapeutics, or nano-sized medicines, are increasingly used beyond cancer treatment for various diseases. Emerging research focuses on safety, biodegradable polymers, and personalized medicine delivery systems.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Nanomedicine
Background:
- Polymer therapeutics are nano-sized medicines increasingly used in clinical practice.
- Initial applications focused on anticancer agents, but use has expanded to other diseases.
- Examples include PEGylated-anti-TNF Fab for rheumatoid arthritis and PEG-aptamer for macular degeneration.
Purpose of the Study:
- To review the current landscape and emerging trends in polymer therapeutics.
- To highlight advancements in drug delivery systems and clinical applications.
- To discuss key areas of ongoing research and development.
Main Methods:
- Literature review of recent advancements in polymer therapeutics.
- Analysis of clinical applications and emerging conjugates.
- Identification of 'hot' topics and research challenges.
Main Results:
- Polymer therapeutics are expanding beyond oncology to treat diverse conditions.
- New conjugates like PEGylated-aptamers and polymer-based siRNA systems are in development.
- Key research areas include polymer safety, biodegradable materials, combination therapies, biomarkers, and regulatory issues.
Conclusions:
- Polymer therapeutics represent a significant advancement in nanomedicine.
- Ongoing research addresses critical aspects for future development and clinical translation.
- The field is dynamic, with continuous innovation in design, application, and regulation.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...